Sung Wan Kang

4PUBLICATIONS
9CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 13, 2026
Dual PARP/Tankyrase Inhibition Enhances Antitumor Efficacy in PTEN-Deficient Endometrial Cancer.

|May 25, 2026
Clinical significance of circulating tumor DNA monitoring based on TP53 mutation in high-grade serous ovarian cancer patients.

|Feb 16, 2024
Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.

Sung Wan Kang, Ok-Ju Kang, Ji-Young Lee

|Sep 10, 2021
Application of Immunoprofiling Using Multiplexed Immunofluorescence Staining Identifies the Prognosis of Patients with High-Grade Serous Ovarian Cancer.

Shin-Wha Lee, Ha-Young Lee, Sung Wan Kang

Pageof 1

Frequent Collaborators

4 joint publications

Shin-Wha Lee

2 joint publications

Min-Seo Lee

2 joint publications

Yong-Man Kim

1 joint publications

Heejung Jung